Enhanced IL-6 signaling has been found to be responsible for cancer development and tumor progression in many human cancers including lung, liver, breast, ovarian, pancreatic, prostate, glioma, lymphoma, melanoma, renal, and colorectal cancers [151,152]. This evidence concerns the gene IL6 and neoplasm.